Nephrol Dial Transplant (2004) 19: 223-226
© ERAEDTA 2003; all rights reserved
Brief Report
Prophylactic bilateral nephrectomies in two paediatric patients with missense mutations in the WT1 gene
1Centre for Kidney Research, 2Department of Nephrology, 3Department of Pathology, 4Department of Surgery and 5The Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, NSW, Australia
Correspondence and offprint requests to: Dr Stephen I. Alexander, Centre for Kidney Research, The Department of Nephrology, The Children's Hospital at Westmead, Locked Bag 4001, Westmead, NSW 2145, Australia. Email: stephena{at}chw.edu.au
Background. DenysDrash syndrome (DDS) is associated with mutations of the Wilms tumour 1 (WT1) gene, and is characterized by pseudohermaphroditism, a progressive glomerulopathy, and the development of Wilms tumour. More than 90% of patients with DDS who carry constitutional intragenic WT1 mutations are at high risk (90%) for the development of Wilms tumour. WT1 is a signalling protein with 90% of WT1 mutations occurring in the WT1 zinc finger region as single nucleotide polymorphisms, the majority of which are missense mutations.
Methods. Constitutional DNA was extracted from peripheral blood. Direct sequencing and restriction enzymes were employed to analyse mutations.
Results. Two children, 46XY males who had evidence of pseudohermaphroditism, hypogonadism and renal failure with a glomerulopathy atypical for DDS, but no Wilms tumour or nephroblastomatosis, on investigation, prior to transplant, were identified with missense mutations in the WT1 gene, in exons 8 and 9, respectively. The decision to do prophylactic nephrectomies was based on the genetic identification of WT1 mutations supporting a diagnosis of incomplete DDS, with the potential for increased risk of malignancy with the development of Wilms tumour. The nephrectomy specimens demonstrated nephrogenic rests (nephroblastomatosis), which have a potential for malignant transformation.
Conclusions. WT1 missense mutations in exons 8 and 9 can be regarded as having the potential for malignant change supporting prophylactic nephrectomy in apparent incomplete DDS patients with end-stage renal disease.
Keywords: DenysDrash syndrome; missense mutations; nephrectomy; WT1